Along with VX-880, it is also working on encapsulated islet cells as a treatment for T1D, although that programme remains in preclinical development. Encapsulation could mean doing away with the ...
which also brought in the encapsulation technology used in VX-264. Since then, the company has expanded its type 1 diabetes cell therapy platform with the $320 million takeover of rival developer ...
According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...
Julien Grogg, PhD, MBA - CEO of Release Therapeutics Release Tx logo Dr. Julien Grogg will Lead the Company's Transition to Clinical ...
Medical Xpress on MSN8d
Viral protein Nef enables a step toward off-the-shelf CAR T cell therapy for cancerCAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...
A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.
The µEncapsulator System from Dolomite Bio enables simple, quick and reliable encapsulation of single cells, DNA and/or functionalized beads in high precision, monodisperse picoliter droplets. The ...
The Cancer Cell and Gene Therapy (CCGT) Program is a component of the overall Center for Cell and Gene Therapy, which is a tri-institutional collaboration among Baylor College of Medicine, Houston ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback